As a potent and safe platform, it induces robust coordinated humoral and cellular immunity and significantly enhances checkpoint blockade efficacy via the enrichment of T<sub>RM</sub> cells in the TME, which underscores its promising potential for the treatment of HER2-positive cancers. This evidence concerns the gene ERBB2 and cancer.